Skip to content
DraconiticResearch
Search Sources API
223,421 studies31 sourcesUpdated 34 min ago
PreprintCC BY 4.0Research Square

Neurodegenerative disorders: Stereotyped relationships between pathological metabolic topographies and the healthy default mode network

Abstract

Background and Objectives: Neurodegenerative disorders are associated with disease-specific networks on metabolic brain imaging. Depending on the disease, the associated pathological topography overlaps to varying degrees with the healthy default mode network (DMN). In this study, we examined the relationships of these networks in various neurodegenerative disorders and in prodromal syndromes. Methods: We analyzed FDG PET scans from 1,117 patients with neurodegenerative disorders manifest by dementia (Alzheimer’s disease (AD), behavioral variant frontotemporal dementia (bvFTD), and dementia with Lewy bodies (DLB)), parkinsonism (Parkinson’s disease (PD) and PD dementia (PDD)), or by mixed/atypical syndromes (progressive supranuclear palsy (PSP), multiple system atrophy (MSA), corticobasal degeneration (CBD), and X-linked dystonia-parkinsonism (XDP)). We also studied scan data from 120 individuals with prodromal syndromes. Topographic relationships between the disease-specific networks and the healthy DMN were assessed by computing spatial similarity indices and voxel-wise correlations. We also computed the expression of the two networks in each patient and in 499 healthy subjects. In each patient group, the resulting values were correlated with each other and with corresponding MMSE scores. Results: The disorders fell into one of three categories based on the topographic relationship of the disease-specific and healthy networks. Category 1 (bvFTD, PSP, CBD, and XDP) was characterized by substantial spatial overlap of the two metabolic networks, tight correlations between their respective expression levels, and significant DMN reductions. Category 2 (PD, AD, DLB, and their associated prodromal syndromes) was characterized by less pronounced overlap, correspondingly weak correlations, and smaller DMN reductions, particularly at prodromal stages. In this group, correlations with MMSE were greater for the difference between disease network and DMN scores than for the disease network alone. Category 3 (MSA) had no discernible network overlap and no loss of DMN expression. Discussion: Category 1 disorders were associated with close relationships between the pathological and healthy topographies, indicating primary DMN involvement. Category 2 disorders were characterized by weaker network relationships, consistent with secondary DMN involvement. Category 3 disorders showed no evidence of DMN involvement. The degree to which disease-specific networks overlap with DMN provides unique insight into the underlying neurodegenerative process.

Related

  1. The pathological roles of intrinsically disordered proteins in lysosomal acidification dysfunction in neurodegenerative diseases.
    Kholoud Abd-ElRaouf, Dylan T Murphy, Lenny Yi Tong Cheong +2
    Translational neurodegenerationPeer-reviewedCC BYFull textPhysiologyEurope PMCPMC
  2. Nanomaterial modulation of lysosomal homeostasis in neurodegenerative proteinopathies: from pathological-protein degradation to re-release and seeding
    Mingrui Song, Nan Bu, Long Wei +1
    Frontiers in molecular neurosciencePeer-reviewedCC BYFull textPhysiologyEurope PMCPMCEurope PMC
  3. Harnessing Artificial Intelligence and ChatGPT in Early Detection of Neurodegenerative Disorders: A Transformative Opportunity for Neurology
    Roberto Tedeschi
    Acta Neurologica TaiwanicaPeer-reviewedCC BY-NC-SAFull text2 citedEpidemiology & public healthDOAJ
  4. Targeting Sirtuins in Neurodegenerative and Psychiatric Disorders: From Molecular Mechanisms to Pharmacological Modulation
    Andrei Florin Păduraru, Raluca-Sînziana Zaharia, Iuliana Roată +5
    Neurology internationalPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Pathological separation utility of plasma neurofilament light chain (NfL) detected by a single-molecule immunoassay platform in neurodegenerative diseases
    Jin Huang, Haiyan Li, Hailan Zhou +4
    BMJ Neurology OpenPeer-reviewedCC BY-NC 4.0Full textNeurologyPMC
BibTeX
@misc{perovnik2026neurodegenerative,
  title = {{Neurodegenerative disorders: Stereotyped relationships between pathological metabolic topographies and the healthy default mode network}},
  author = {Matej Perovnik and David Eidelberg},
  howpublished = {Research Square},
  year = {2026},
  month = oct,
  doi = {10.21203/rs.3.rs-11320531/v1},
  url = {https://doi.org/10.21203/rs.3.rs-11320531/v1},
  note = {CC BY 4.0},
}
RIS
TY  - UNPB
TI  - Neurodegenerative disorders: Stereotyped relationships between pathological metabolic topographies and the healthy default mode network
AU  - Matej Perovnik
AU  - David Eidelberg
PY  - 2026
DA  - 2026/10/13
PB  - Research Square
DO  - 10.21203/rs.3.rs-11320531/v1
UR  - https://doi.org/10.21203/rs.3.rs-11320531/v1
AB  - Background and Objectives: Neurodegenerative disorders are associated with disease-specific networks on metabolic brain imaging. Depending on the disease, the associated pathological topography overlaps to varying degrees with the healthy default mode network (DMN). In this study, we examined the relationships of these networks in various neurodegenerative disorders and in prodromal syndromes. Methods: We analyzed FDG PET scans from 1,117 patients with neurodegenerative disorders manifest by dementia (Alzheimer’s disease (AD), behavioral variant frontotemporal dementia (bvFTD), and dementia with Lewy bodies (DLB)), parkinsonism (Parkinson’s disease (PD) and PD dementia (PDD)), or by mixed/atypical syndromes (progressive supranuclear palsy (PSP), multiple system atrophy (MSA), corticobasal degeneration (CBD), and X-linked dystonia-parkinsonism (XDP)). We also studied scan data from 120 individuals with prodromal syndromes. Topographic relationships between the disease-specific networks and the healthy DMN were assessed by computing spatial similarity indices and voxel-wise correlations. We also computed the expression of the two networks in each patient and in 499 healthy subjects. In each patient group, the resulting values were correlated with each other and with corresponding MMSE scores. Results: The disorders fell into one of three categories based on the topographic relationship of the disease-specific and healthy networks. Category 1 (bvFTD, PSP, CBD, and XDP) was characterized by substantial spatial overlap of the two metabolic networks, tight correlations between their respective expression levels, and significant DMN reductions. Category 2 (PD, AD, DLB, and their associated prodromal syndromes) was characterized by less pronounced overlap, correspondingly weak correlations, and smaller DMN reductions, particularly at prodromal stages. In this group, correlations with MMSE were greater for the difference between disease network and DMN scores than for the disease network alone. Category 3 (MSA) had no discernible network overlap and no loss of DMN expression. Discussion: Category 1 disorders were associated with close relationships between the pathological and healthy topographies, indicating primary DMN involvement. Category 2 disorders were characterized by weaker network relationships, consistent with secondary DMN involvement. Category 3 disorders showed no evidence of DMN involvement. The degree to which disease-specific networks overlap with DMN provides unique insight into the underlying neurodegenerative process.
SN  - 2693-5015
ER  -